1. Home
  2. NSPR vs GEG Comparison

NSPR vs GEG Comparison

Compare NSPR & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • GEG
  • Stock Information
  • Founded
  • NSPR 2005
  • GEG 1994
  • Country
  • NSPR United States
  • GEG United States
  • Employees
  • NSPR N/A
  • GEG N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • GEG Computer Software: Prepackaged Software
  • Sector
  • NSPR Health Care
  • GEG Technology
  • Exchange
  • NSPR Nasdaq
  • GEG Nasdaq
  • Market Cap
  • NSPR 74.8M
  • GEG 63.0M
  • IPO Year
  • NSPR N/A
  • GEG N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • GEG $2.47
  • Analyst Decision
  • NSPR Strong Buy
  • GEG
  • Analyst Count
  • NSPR 2
  • GEG 0
  • Target Price
  • NSPR $4.50
  • GEG N/A
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • GEG 9.4K
  • Earning Date
  • NSPR 08-05-2025
  • GEG 09-02-2025
  • Dividend Yield
  • NSPR N/A
  • GEG N/A
  • EPS Growth
  • NSPR N/A
  • GEG N/A
  • EPS
  • NSPR N/A
  • GEG N/A
  • Revenue
  • NSPR $7,066,000.00
  • GEG $19,626,000.00
  • Revenue This Year
  • NSPR $4.85
  • GEG N/A
  • Revenue Next Year
  • NSPR $113.47
  • GEG N/A
  • P/E Ratio
  • NSPR N/A
  • GEG N/A
  • Revenue Growth
  • NSPR 7.60
  • GEG 64.34
  • 52 Week Low
  • NSPR $1.99
  • GEG $1.70
  • 52 Week High
  • NSPR $3.80
  • GEG $2.54
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • GEG 73.25
  • Support Level
  • NSPR $2.35
  • GEG $2.06
  • Resistance Level
  • NSPR $2.52
  • GEG $2.54
  • Average True Range (ATR)
  • NSPR 0.14
  • GEG 0.10
  • MACD
  • NSPR -0.02
  • GEG 0.04
  • Stochastic Oscillator
  • NSPR 7.50
  • GEG 86.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.

Share on Social Networks: